Clinical Trials Browser

Completed × INDUSTRY × apaziquone × Clear all

NCT00461591 2021-03-30

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)

Phase 3 Completed

802 enrolled 20 charts

Urinary Bladder Neoplasms

NCT00141531 2012-06-14

Phase II Trial of EOquin in High-risk Superficial Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma in Situ